CT enterography in the evaluation of Crohn's disease  by dos Santos, Carlos Henrique Marques et al.
j coloproctol (rio j). 2 0 1 5;3  5(4):217–222
Journal  of
O
C
d
C
T
a
b
c
a
A
R
A
A
K
C
E
D
P
D
E
D
h
2www.jco l .org .br
Coloproctology
riginal Article
T  enterography  in the  evaluation  of  Crohn’s
isease
arlos Henrique Marques dos Santosa,∗, Jovino Nogueira da Silva Menezesb,
hiago  Franchi Nunesc, Letícia de Assis Martinsc
Service of Coloproctology, Hospital Universitário Maria Aparecida Pedrossian, Campo Grande, MS, Brazil
Service of General Surgery, Hospital Universitário Maria Aparecida Pedrossian, Campo Grande, MS, Brazil
Service of Radiology, Hospital Universitário Maria Aparecida Pedrossian, Campo Grande, MS, Brazil
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 28 March 2015
ccepted 8 June 2015
vailable online 2 October 2015
eywords:
rohn’s disease
nterography
iagnosis
a  b  s  t  r  a  c  t
Proposition: Crohn’s disease (CD) is a chronic inﬂammatory process that affects various parts
of  the gastrointestinal tract, from the mouth to the anus with unknown etiology and variable
clinical presentation. CD diagnosis is based on clinical and complementary tests. Among
the  complementary tests, enterography with CT enterography has shown good results in
the  evaluation of this disease.
Methods: The patients evaluated were submitted to a questionnaire on the clinical manifes-
tations of the disease and an CT enterography was obtained. The studies were reviewed by
an  experienced radiologist looking for radiological signs of CD.
Results: The mean age was 40 years, with a predominance of women. The main clinical
manifestations are diarrhea in 24 (70%), hematochezia in 19 (55%), abdominal pain in 29
(85%)  and weight loss in 22 (64%) patients. The main ﬁndings on CT enterography were an
intestinal wall enhancement signal in 23 patients (67%), vascular engorgement (vasa recta)
in  20 (58%), parenteral fat densiﬁcation in 14 (41%), intestinal wall thickening in 22 (64%),
and  lymph node enlargement in 17 (50%) of patients.
Conclusion: This study showed that CT enterography presents a good assessment of intesti-
nal involvement by CD.
©  2015 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. All
rights reserved.
Enterograﬁa  por  tomograﬁa  computadorizada  na  avaliac¸ão  da  doenc¸a de
Crohn
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Proposic¸ão: A doenc¸a de Crohn (DC) é um processo inﬂamatório crônico que acomete vários
locais do trato gastrointestinal, desde a boca até o ânus, tendo etiologia desconhecida e
apresentac¸ão  clinica variável. Seu diagnóstico baseia- se no exame clinico e em testes
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complementares. Dentre os exames complementares, a Enterograﬁa por Tomograﬁa Com-
putadorizada (Entero-TC) tem mostrado bons resultados na avaliac¸ão dessa doenc¸a.
Metodologia: Os pacientes avaliados foram submetidos a um questionário sobre as
manifestac¸ões clinicas da doenc¸a e realizaram Entero-TC. Esses exames foram analisados
por  um radiologista experiente, à procura de sinais radiológicos da DC.
Resultados: A idade média foi de 40 anos, com predomínio de mulheres. As principais
manifestac¸ões clínicas foram diarreia em 24 (70%), hematoquezia em 19 (55%), dor abdom-
inal em 29 (85%) e perda de peso em 22 (64%) dos pacientes. Os principais achados na
Entero-TC foram o sinal de realce de parede intestinal em 23 pacientes (67%), ingurgitamento
vascular (vasa recta) em 20 (58%), densiﬁcac¸ão de gordura perientérica em 14 (41%), espes-
samento de parede intestinal em 22 (64%) e linfonodomegalia em 17 (50%) dos pacientes
avaliados.
Conclusão: O presente estudo mostrou que a Entero-TC apresenta boa avaliac¸ão do acome-
timento intestinal pela DC.
© 2015 Sociedade Brasileira de Coloproctologia. Publicado por Elsevier Editora Ltda.
Todos os direitos reservados.Introduction
Crohn’s disease (CD) is a chronic inﬂammatory process that
affects various parts of the gastrointestinal tract, from the
mouth to the anus.1,2 CD has shown an increase in its preva-
lence since the second half of the twentieth century and,
despite major advances in understanding the basic mecha-
nisms of inﬂammation and pathogenesis, its cause remains
unknown.1
With an extremely variable clinical presentation, CD
exhibits symptoms and prevalent injuries that differ according
to their location, extent, systemic manifestations and poten-
tial complications. In general, CD exhibits as early symptoms:
abdominal pain, associated with persistent diarrhea, weight
loss, mild fever and extra-intestinal manifestations.2
The diagnosis of CD is based on the analysis of clini-
cal data, as history and a complete physical and proctologic
examination, besides endoscopic, radiological, laboratory and
histological tests.3 Undoubtedly, colonoscopy has proven to
be the test of choice for the diagnosis of this disease, since
it allows a complete evaluation of the large bowel, ileocecal
valve and terminal ileum, areas commonly affected by the dis-
ease. However, in its most part, the small intestine cannot be
evaluated by this method.
For several years, barium studies were considered as the
gold standard in the investigation of diseases of the small
intestine, for example, conventional enteroclysis and intesti-
nal transit,3 with great impact on the diagnosis, evaluation
of their anatomical distribution, the presence of complica-
tions such as stencils, ﬁstulae, abscesses, and signs of acute
exacerbation.4
With the development of imaging studies, the enterogra-
phy, either by computed tomography or magnetic resonance
imaging, is replacing the intestinal transit and enteroclysis
procedures in the imaging evaluation of the small intestine.
The advantage of CT enterography is to allow a visualization
of the entire small intestine, without overlapping loops, thus
allowing the evaluation of the intestinal wall, detection of
extra-luminal pathological conditions, and potential associ-
ated changes.Many of these ﬁndings are not seen in traditional endo-
scopic studies, which favors the progressive replacement of
old methods by the enterography as the main method of diag-
nosis of inﬂammatory bowel disease (IBD).5–8
The early studies with CT enterography showed a high
degree of sensitivity, above 85%, for the diagnosis of active
CD, when compared with barium enteroclysis. Recent studies
have demonstrated a sensitivity rate of up to 100% and speci-
ﬁcity of 53.9% for the identiﬁcation of CD in its active phase.7
Other papers have shown that CT enterography is equivalent
to MR enterography for the assessment of CD activity.
Despite studies showing good results with CT enterogra-
phy, there are few publications on this subject in Brazil; thus,
it is essential to carry out this study in our midst.
Goal
The aim of this study was to analyze the radiological ﬁndings
of CT enterography, relating them to the clinical manifesta-
tions in patients with CD.
Method
The study was approved by the Ethics Committee of the
Federal University of Mato Grosso do Sul. After reading
and signing an informed consent form, patients diagnosed
with Crohn’s disease referred from Coloproctology Outpatient
Clinics of Hospital Universitário Maria Aparecida Pedrossian
and Hospital Regional de Mato Grosso do Sul were stud-
ied.
Patients diagnosed with Crohn’s disease, aged over 18
years, and already evaluated by colonoscopy were included.
Patients with a known gastrointestinal tract neoplasia,
patients with gastrointestinal symptoms such as nausea and
vomiting, pregnant women, and patients with allergy to
iodinated contrast or with creatinine above 2.0 mg/dl were
excluded from this study.All participants responded to a questionnaire (Fig. 1) on
Crohn’s disease about symptoms and signs at presentation
and current medication.
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Fig. 1 – Enterography by computed tomography of
abdomen (sagittal section) showing luminal dilation, wall
thickening and contrast hyper-uptake.
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patients. Abscesses were also seen in four (11%) patients, with
location on the left ischioanal fossa, at the colostomy site, right
Caucasian
Race or Color
Black
Brown
YellowRegarding the medication used, these drugs were classi-
ed as immunosuppressants (azathioprine), salicylates (oral
esalazine), topical salicylates (mesalazine enemas and
uppositories), corticosteroids (prednisone and budesonide),
iologicals (inﬂiximab and adalimumab) and antibiotics
metronidazole and ciproﬂoxacin).
An oral neutral contrast, polyethylene glycol solution
Muvinlax®), commercially available as sachets with 13.125 g,
as used as per protocol in the procedures. This product was
iluted as follows: ﬁve sachets (65.625 g) in 1500 mL of water
43.75 g/L), administered during 40 min. Then, the partici-
ants underwent computed tomography (CT) of the abdomen
nd pelvis. An Aquilon-64 tomograph with 64 rows of detec-
ors (Toshiba Medical Systems, Tokyo, Japan) was used. The
xaminations were performed with multislice technique and
olumetric acquisition, extending from the diaphragm to the
ubic symphysis, 65 s after starting the intravenous injec-
ion of contrast medium. The contrast was injected at a rate
f approximately 3 mL/s in a proportion of 1.5 mL/kg, with
 maximum volume of 150 mL.  The technical parameters
sed in CT scans were as follows: collimation 64 × 0.625 mm,
itch = 0.891, 3-mm thick, 120 kVp, and mAs  = 1 mm.  Coronal
nd sagittal reconstructions were obtained.
The scans were interpreted by a single radiologist with
xtensive experience in CT enterography; this professional
as blinded to clinical information at his workstation. The
valuator conducted an analysis as to the degree of intesti-
al distension, divided into four areas of bowel segments:
eft hypocondrium, mesogastrium, pelvis and terminal ileum.
ach region was rated according to a scale from 1 to 3, as fol-
ows: 1 – loops <1 cm diameter; 2 – loops with 1–2 cm diameter; – loops >2 cm diameter. Furthermore, the radiologist classi-
ed the loop walls as visible or non-visible, also in the four
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The following ﬁndings indicative of disease activity were
observed with CT enterography: wall thickening, increased
intestinal wall enhancement, parietal stratiﬁcation, par-
enteral fat densiﬁcation, vascular engorgement (vasa recta),
lymphadenomegaly, ﬁstulae or abscesses.
Data were analyzed using the Excel Windows® program
2007. The ﬁndings of CT enterography were then correlated
with the clinical ﬁndings obtained through the questionnaire
on the disease.
All information on the identity of the research subjects
and on questionnaires complied with the ethical principles
of research set out in the National Health Council Resolution
466/12.
Results
A good tolerance of all patients with oral contrast intake was
noted, and all tests have been completed, totaling 34 studies.
Ages ranged from 18 to 67 years (mean, 40 years). Of our 34
patients, 20 (58%) were female and 14 (42%) were male. As for
race or color, 18 (52%) reported Caucasian ascend, four (11%)
Black, 11 (32%) Brown (2%) and 1 Yellow patient (Fig. 2).
The main clinical manifestations were diarrhea in 24 (70%),
hematochezia in 19 (55%), abdominal pain in 29 (85%), and
weight loss in 22 (64%) patients (Fig. 3).
Twenty-ﬁve patients (73.5%) were under pharmacological
treatment. The major drugs used were azathioprine (52%), oral
mesalamine (44%) and prednisone (44%), some of these used
in combination (Table 1). Nine patients (36%) were using only
one drug, especially salicylate (44%), while 13 (38%) were using
more  than one drug (Table 2).
The main ﬁndings of CT enterography were intestinal wall
signal enhancement in 23 patients (67%), vascular engorge-
ment (vasa recta) in 20 (58%), perienteral fat densiﬁcation in
14 (41%), and bowel wall thickening in 22 (64%) (Table 3 and
Figs. 1 and 4). Lymphadenomegaly was observed in 17 (50%)Fig. 2 – Distribution of patients according to race or
ethnicity.
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Fig. 3 – Signs and symptoms presented by our patients according to the questionnaire applied. Note: some patients
presented more  than one clinical manifestation.
Table 1 – Medication in current use.
Drug n %
Azathioprine 13 52
Mesalazine tablet 11 44
Mesalamine suppository 2 8
Mesalazine enema 3 12
Prednisone 11 44
Adalimumab 4 16
Inﬂiximab 4 16
Ciproﬂoxacin 2 8
Metronidazole 2 8
Note:  some patients used more than one medication.
Table 2 – Distribution of patients by drugs used in a
monotherapy regimen.
Therapy n %
Immunosuppressive 2 22
Salicylate, topical 0 0
Salicylate, oral 4 44
Corticoids 2 22
Biologicals 1 11
Antibiotics 0 0
Total 9 100
Table 3 – Radiological ﬁndings of CT enterography.
Radiological signs n %
Intestinal wall enhancement 23 67
Intestinal wall thickening 22 64
Vascular engorgement (vasa recta) 20 58
Reactive lymph nodes 17 50
Mesenteric fat densiﬁcation 14 41
Stenosis 12 35
Target or double halo signal 9 26
Fistulae 5 14
Abscesses 4 11
Note:  some studies presented more than one ﬁnding.iliac fossa and in a left extraperitoneal area. The most affected
bowel segments were ileum and right colon (Table 4 and Fig. 5).
The combination of perianal lesions in association with uri-
nary tract infection was present in 10 (29%) patients; two  (5.8%)
were men  and eight (23%) were women. Diarrhea and weight
loss were observed in 19 (55%) patients.
Fig. 4 – Enterography by computed tomography of abdomen
(coronal section) showing wall thickening, luminal
narrowing, “comb” signal and contrast hyper-uptake.
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Table 4 – Intestinal segments affected found in CT
enterography.
Intestinal segment n %
Duodenum 0 0
Jejunum 0 0
Ileum 11 32
Right colon 9 26
Appendix 5 15
Left colon 6 18
Rectum 7 21
Colostomy 1 3
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wNote:  some patients presented more than one affected segment.
With the development of imaging studies, the enterogra-
hy, either by computed tomography or magnetic resonance,
s replacing intestinal transit and enteroclysis procedures in
he evaluation of the small bowel by imaging procedures. The
dvantage of CT enterography is that this procedure allows
isualization of the entire small intestine, without loop over-
apping, and also allows the evaluation of the intestinal wall,
etection of extra-luminal pathological conditions, and poten-
ial associated changes.
Many  of these ﬁndings are not seen in traditional endo-
copic studies, which supports the progressive replacement of
ld methods by enterography as the main method of diagnosis
or inﬂammatory bowel disease (IBD).5–8Early studies with CT enterography showed a high degree
f sensitivity, above 85%, for the diagnosis of active CD ver-
us barium enteroclysis. Recent studies have demonstrated a
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sensitivity rate of up to 100%, and 53.9% speciﬁcity for the
identiﬁcation of CD in its active phase.7 Other publications
have shown that CT enterography is equivalent to MR enterog-
raphy in the assessment of CD activity.
Despite studies showing good results with CT enterogra-
phy, there are few publications on this subject in Brazil; thus,
it is critical that this study is carried out in our midst.
Discussion
CT enterography has a clinical application in the evaluation
of patients with CD, to conﬁrm the diagnosis of the disease
or its extension and complications in the assessment of small
bowel.3 Nowadays, CT enterography constitutes an excellent
option for replacement of lower-accuracy radiological meth-
ods and as an alternative versus endoscopic capsule, a very
expensive technology.
As in other studies,2 we also observed predominance of
female patients (58%), and higher incidence in Caucasians,
followed by Brown, Yellow, and Black patients.
In this paper, the sectors most affected by CD lesions were
ileum (32%) followed by right colon (26%). If the involvement
of cecal appendix (14%) is included, a clear predominance of
involvement in the ileocecal transition will be noted, accord-
ing to the literature. The large intestine was the second
most affected area, also according to observations by other
authors.9–11
The most observed radiological signs in this study
were intestinal wall enhancement and thickening, vascular
engorgement, reactive lymph nodes, and perienteral fat den-
siﬁcation, which is in agreement with the literature, since
Costa-Silva et al.3 and Ilangovan et al.12 found similar results.
Considering that, at its inception, DC usually presents in
the inﬂammatory form, one can really expect that there are
large numbers of patients with wall thickening and vascular
engorgement. Whereas most of our patients evaluated had
recent diagnoses, actually these were the expected ﬁndings.
In this study, these changes were observed in 88% of patients.
Aﬁﬁ et al.13 also observed these key ﬁndings in patients with
active Crohn’s disease. Moreover, these authors compared
these changes versus surgical evaluation of patients under-
going resection due to CD, and found a good clinical and
radiological correlation.
There seems to be no large difference in accuracy when
comparing CT enterography versus MR enterography, except
that tomography is superior in detecting infectious com-
plications; and for this reason, often this technique is
recommended as ﬁrst choice in the evaluation of the small
intestine, immediately after diagnosis, as well as in cases
where there is suspicion of abdominal abscesses. In the fol-
lowing revaluations, maybe there is a greater advantage with
the use of resonance, because this technique does not expose
the patient to ionizing radiation. In this study, we  chose to use
CT enterography because this is the procedure available in our
environment – a fact that is also observed in most Brazilian
medical centers, especially among public tertiary hospitals,
where there is a much higher number of tomographs in com-
parison with magnetic resonance imaging machines.
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Perianal lesions associated with urinary tract infection
were present in 10 (29%) patients, two (5.8%) men  and eight
(23%) women. Diarrhea and weight loss were observed in 19
(55%) patients. Such an association may be related to the mal-
absorption syndrome observed in CD patients.2
Importantly, cross-sectional studies reﬂect certain
moments of the sample; thus, changes may occur in several
aspects analyzed over time, and with the inclusion of new
patients.
Conclusion
The study allows one to observe that the main radiological
ﬁndings of CT enterography were intestinal wall enhancement
and thickening and vascular engorgement, mainly affecting
the ileum and right colon. The main clinical manifestations
in our patients were diarrhea and abdominal pain.
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